Research & Clinical Trials
- Genes related to HCC progression in liver transplant recipients
-
- Investigator: Abraham Shaked, MD, PhD
- Sponsored by: NIH/NIDDK
- Molecular profiling and donor and recipient pro inflammatory and alloimmune response
-
- Investigator: Abraham Shaked, MD, PhD
- Sponsored by: National Institutes of Health
- Tissue and serum bank
-
- Investigator: Kim Olthoff, MD
- Gene expression and regenerative pathways in donor livers
-
- Investigator: Kim Olthoff, MD
- Sponsored by: National Institutes of Health
- A phase II trial to assess the safety of immunosuppression withdrawal in liver transplant recipients with hepatitis C
-
- Investigator: Abraham Shaked, MD, PhD
- Sponsored by: Immune Tolerance Network
- Validation of serum markers for the early detection of hepatocellular carcinoma (DCP)
-
- Investigator: K. Rajender Reddy, MD
- Sponsored by: National Cancer Institute
- A2 ALL: adult-to-adult living donor liver transplant cohort study)
-
- Investigator: Abraham Shaked, MD, PhD
- Sponsored by: National Institutes of Health
- A2 ALL: adult-to-adult living donor liver transplant cohort study)
-
- Investigator: Abraham Shaked, MD, PhD
- Sponsored by: National Institutes of Health
- Clinical, immunologic and pharmacologic consequences of liver transplantation in people with HIV infection
-
- Investigator: Kim Olthoff, MD
- Sponsored by: National Institutes of Health
- Comparative evaluation of inhibitor treatments in liver allograft recipients
-
- Investigator: K. Rajender Reddy, MD
- Comparative safety and efficacy study of prophylactic interferon following liver transplantation for hepatitis C
-
- Investigator: K. Rajender Reddy, MD
- Sponsored by: National Institutes of Health
- Safety and efficacy study of N-acetylcysteine in the treatment of acute liver failure not caused by acetaminophen in adult patients
-
- Investigator: K. Rajender Reddy, MD
- Sponsored by: National Institutes of Health
- An observational database of patients who receive orthotopic liver transplantation (OLT) for hepatitis B
-
- Investigator: K. Rajender Reddy, MD
- Comparison of HepeX-BTM, a mixture of two monoclonal antibodies, to hepatitis B immune globulin in patients who have received hepatic allografts for treatment of end-stage liver disease due to hepatitis B virus infection
-
- Investigator: K. Rajender Reddy, MD
- Intravenous terlipressin in patients with hepatorenal syndrome type I
-
- Investigator: K. Rajender Reddy, MD
For more information about clinical trials at the Penn Transplant Institute, see Research & Clinical Trials.